Hologic, Inc’s filing revealed that its Director Madaus Martin D acquired Company’s shares for reported $0.3 million on May 07 ’25. In the deal valued at $55.24 per share,5,445 shares were bought. As a result of this transaction, Madaus Martin D now holds 5,445 shares worth roughly $0.35 million.
Then, Mitchell Essex D sold 24,856 shares, generating $1,897,482 in total proceeds. Upon selling the shares at $76.34, the Chief Operating Officer now owns 27,957 shares.
Before that, Mitchell Essex D bought 24,856 shares. Hologic, Inc shares valued at $1,897,484 were divested by the Officer at a price of $76.34 per share.
Needham reiterated its Hologic, Inc [HOLX] rating to a Hold in a research note published recently. A number of analysts have revised their coverage, including Argus’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Hold”. Leerink Partners also remained covering HOLX and has decreased its forecast on February 06, 2025 with a “Market perform” recommendation from previously “an Outperform” rating. Needham revised its rating on February 03, 2025. It rated HOLX as “a Hold” which previously was an “a Buy”.
Price Performance Review of HOLX
On Friday, Hologic, Inc [NASDAQ:HOLX] saw its stock fall -0.72% to $64.75. Over the last five days, the stock has gained 0.65%. Hologic, Inc shares have fallen nearly -10.18% since the year began. Nevertheless, the stocks have fallen -11.18% over the past one year. While a 52-week high of $84.67 was reached on 01/06/25, a 52-week low of $51.90 was recorded on 05/06/25.
Levels Of Support And Resistance For HOLX Stock
The 24-hour chart illustrates a support level at 64.28, which if violated will result in even more drops to 63.81. On the upside, there is a resistance level at 65.35. A further resistance level may holdings at 65.95.
How much short interest is there in Hologic, Inc?
A steep rise in short interest was recorded in Hologic, Inc stocks on 2025-05-30, dropping by -0.24 million shares to a total of 5.11 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 5.35 million shares. There was a decline of -4.71%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 13, 2024 when Wolfe Research began covering the stock and recommended ‘”a Peer perform”‘ rating .
